Effects of biochemically confirmed smoking cessation on white blood cell count

Gregory A. Abel, James Taylor Hays, Paul A. Decker, Gary A. Croghan, David J. Kuter, Nancy A. Rigotti

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

OBJECTIVES: To determine the relationship between white blood cell (WBC) indices and several baseline variables in a large cohort of healthy smokers and to assess whether these changed after biochemically confirmed smoking cessation. SUBJECTS AND METHODS: The study consisted of 784 healthy smokers enrolled in a trial of sustained-release bupropion, 300 mg/d, for relapse prevention after smoking cessation from 1995 to 1998. Both WBC counts and absolute neutrophil counts (ANCs) were measured at baseline, week 7, and week 52. Smoking status was assessed at weeks 7 and 52 by self-report and biochemically confirmed with expired air carbon monoxide levels. Multivariate analyses compared changes in WBC count and ANC between smokers who did and did not stop smoking, adjusting for treatment group, age, sex, and body mass index. RESULTS: Of 784 smokers enrolled, 461 had biochemically confirmed tobacco abstinence after 7 weeks of bupropion; 429 were randomly assigned to receive continued bupropion therapy or placebo until week 52. Between baseline and week 7, there was a significantly larger decrease in WBC count in continuously abstinent subjects compared with continuing smokers (adjusted P=.03). At 52 weeks, continuously abstinent subjects, compared with continuing smokers, had a greater decline from baseline in WBC count (1.2±1.9 × 109/L vs 0.1±1.9 × 109/L; P<.001) and ANC (1.0±1.6 × 109/L vs 0.2±1.5 × 109/L; P<.001). CONCLUSION: Biochemically confirmed tobacco abstinence leads to a rapid and sustained decrease in WBC and ANC, possibly reflecting a decrease in an underlying state of tobacco-induced inflammation.

Original languageEnglish (US)
Pages (from-to)1022-1028
Number of pages7
JournalMayo Clinic Proceedings
Volume80
Issue number8
StatePublished - 2005

Fingerprint

Smoking Cessation
Leukocyte Count
Bupropion
Neutrophils
Tobacco
Leukocytes
Smoking
Carbon Monoxide
Secondary Prevention
Self Report
Body Mass Index
Multivariate Analysis
Age Groups
Air
Placebos
Inflammation
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Abel, G. A., Hays, J. T., Decker, P. A., Croghan, G. A., Kuter, D. J., & Rigotti, N. A. (2005). Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clinic Proceedings, 80(8), 1022-1028.

Effects of biochemically confirmed smoking cessation on white blood cell count. / Abel, Gregory A.; Hays, James Taylor; Decker, Paul A.; Croghan, Gary A.; Kuter, David J.; Rigotti, Nancy A.

In: Mayo Clinic Proceedings, Vol. 80, No. 8, 2005, p. 1022-1028.

Research output: Contribution to journalArticle

Abel, GA, Hays, JT, Decker, PA, Croghan, GA, Kuter, DJ & Rigotti, NA 2005, 'Effects of biochemically confirmed smoking cessation on white blood cell count', Mayo Clinic Proceedings, vol. 80, no. 8, pp. 1022-1028.
Abel GA, Hays JT, Decker PA, Croghan GA, Kuter DJ, Rigotti NA. Effects of biochemically confirmed smoking cessation on white blood cell count. Mayo Clinic Proceedings. 2005;80(8):1022-1028.
Abel, Gregory A. ; Hays, James Taylor ; Decker, Paul A. ; Croghan, Gary A. ; Kuter, David J. ; Rigotti, Nancy A. / Effects of biochemically confirmed smoking cessation on white blood cell count. In: Mayo Clinic Proceedings. 2005 ; Vol. 80, No. 8. pp. 1022-1028.
@article{9c96cb5898ca47218c267e1b7403025d,
title = "Effects of biochemically confirmed smoking cessation on white blood cell count",
abstract = "OBJECTIVES: To determine the relationship between white blood cell (WBC) indices and several baseline variables in a large cohort of healthy smokers and to assess whether these changed after biochemically confirmed smoking cessation. SUBJECTS AND METHODS: The study consisted of 784 healthy smokers enrolled in a trial of sustained-release bupropion, 300 mg/d, for relapse prevention after smoking cessation from 1995 to 1998. Both WBC counts and absolute neutrophil counts (ANCs) were measured at baseline, week 7, and week 52. Smoking status was assessed at weeks 7 and 52 by self-report and biochemically confirmed with expired air carbon monoxide levels. Multivariate analyses compared changes in WBC count and ANC between smokers who did and did not stop smoking, adjusting for treatment group, age, sex, and body mass index. RESULTS: Of 784 smokers enrolled, 461 had biochemically confirmed tobacco abstinence after 7 weeks of bupropion; 429 were randomly assigned to receive continued bupropion therapy or placebo until week 52. Between baseline and week 7, there was a significantly larger decrease in WBC count in continuously abstinent subjects compared with continuing smokers (adjusted P=.03). At 52 weeks, continuously abstinent subjects, compared with continuing smokers, had a greater decline from baseline in WBC count (1.2±1.9 × 109/L vs 0.1±1.9 × 109/L; P<.001) and ANC (1.0±1.6 × 109/L vs 0.2±1.5 × 109/L; P<.001). CONCLUSION: Biochemically confirmed tobacco abstinence leads to a rapid and sustained decrease in WBC and ANC, possibly reflecting a decrease in an underlying state of tobacco-induced inflammation.",
author = "Abel, {Gregory A.} and Hays, {James Taylor} and Decker, {Paul A.} and Croghan, {Gary A.} and Kuter, {David J.} and Rigotti, {Nancy A.}",
year = "2005",
language = "English (US)",
volume = "80",
pages = "1022--1028",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - Effects of biochemically confirmed smoking cessation on white blood cell count

AU - Abel, Gregory A.

AU - Hays, James Taylor

AU - Decker, Paul A.

AU - Croghan, Gary A.

AU - Kuter, David J.

AU - Rigotti, Nancy A.

PY - 2005

Y1 - 2005

N2 - OBJECTIVES: To determine the relationship between white blood cell (WBC) indices and several baseline variables in a large cohort of healthy smokers and to assess whether these changed after biochemically confirmed smoking cessation. SUBJECTS AND METHODS: The study consisted of 784 healthy smokers enrolled in a trial of sustained-release bupropion, 300 mg/d, for relapse prevention after smoking cessation from 1995 to 1998. Both WBC counts and absolute neutrophil counts (ANCs) were measured at baseline, week 7, and week 52. Smoking status was assessed at weeks 7 and 52 by self-report and biochemically confirmed with expired air carbon monoxide levels. Multivariate analyses compared changes in WBC count and ANC between smokers who did and did not stop smoking, adjusting for treatment group, age, sex, and body mass index. RESULTS: Of 784 smokers enrolled, 461 had biochemically confirmed tobacco abstinence after 7 weeks of bupropion; 429 were randomly assigned to receive continued bupropion therapy or placebo until week 52. Between baseline and week 7, there was a significantly larger decrease in WBC count in continuously abstinent subjects compared with continuing smokers (adjusted P=.03). At 52 weeks, continuously abstinent subjects, compared with continuing smokers, had a greater decline from baseline in WBC count (1.2±1.9 × 109/L vs 0.1±1.9 × 109/L; P<.001) and ANC (1.0±1.6 × 109/L vs 0.2±1.5 × 109/L; P<.001). CONCLUSION: Biochemically confirmed tobacco abstinence leads to a rapid and sustained decrease in WBC and ANC, possibly reflecting a decrease in an underlying state of tobacco-induced inflammation.

AB - OBJECTIVES: To determine the relationship between white blood cell (WBC) indices and several baseline variables in a large cohort of healthy smokers and to assess whether these changed after biochemically confirmed smoking cessation. SUBJECTS AND METHODS: The study consisted of 784 healthy smokers enrolled in a trial of sustained-release bupropion, 300 mg/d, for relapse prevention after smoking cessation from 1995 to 1998. Both WBC counts and absolute neutrophil counts (ANCs) were measured at baseline, week 7, and week 52. Smoking status was assessed at weeks 7 and 52 by self-report and biochemically confirmed with expired air carbon monoxide levels. Multivariate analyses compared changes in WBC count and ANC between smokers who did and did not stop smoking, adjusting for treatment group, age, sex, and body mass index. RESULTS: Of 784 smokers enrolled, 461 had biochemically confirmed tobacco abstinence after 7 weeks of bupropion; 429 were randomly assigned to receive continued bupropion therapy or placebo until week 52. Between baseline and week 7, there was a significantly larger decrease in WBC count in continuously abstinent subjects compared with continuing smokers (adjusted P=.03). At 52 weeks, continuously abstinent subjects, compared with continuing smokers, had a greater decline from baseline in WBC count (1.2±1.9 × 109/L vs 0.1±1.9 × 109/L; P<.001) and ANC (1.0±1.6 × 109/L vs 0.2±1.5 × 109/L; P<.001). CONCLUSION: Biochemically confirmed tobacco abstinence leads to a rapid and sustained decrease in WBC and ANC, possibly reflecting a decrease in an underlying state of tobacco-induced inflammation.

UR - http://www.scopus.com/inward/record.url?scp=23244453498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244453498&partnerID=8YFLogxK

M3 - Article

VL - 80

SP - 1022

EP - 1028

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -